You searched for Antibody candidate - Page 59 of 69

topas therapeutics timm jessen interview

Interview 15 Nov 2017

Therapeutic Nanoparticle Companies Are Rare: Meet the CEO of One of Them

…a consortium working on multiple sclerosis and where it’s going now. Topas has its lead candidate in MS, which as Jessen describes, “is a very difficult disease [because] even the…

November 15, 2017 - 4 minutesmins - By Evelyn Warner

Best in Biotech 24 Oct 2023

Seven molecular glue startups looking to stick around in the biotech industry

…Now, there are a rising number of molecular glue companies hoping to show clinical success with their candidates. The term molecular glue refers to a small molecule that sticks two…

October 24, 2023 - 9 minutesmins - By Willow Shah-Neville

In Depth 23 Nov 2023

The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy

…acts as an undercover agent to release other immune cells in the TME, as they would usually have much more barriers to entry. CT-0508: Carisma’s encouraging candidate in addressing HER2+…

November 23, 2023 - 5 minutesmins - By Jules Adam

News and Trends 16 Feb 2016

Sorry Scotland, Phase II Trial for Clinical Depression Fails against 55-Year Old Generic

…plan was that this candidate would have more benign side effects and a better tolerance profile than tricyclic antidepressants like amitriptyline (also a popular painkiller on the market). Having already…

February 16, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 16 Dec 2022

Sosei Heptares and Lilly enter agreement on diabetes and metabolic diseases

…target-selective small molecule hit candidates for further development and commercialization. Sosei Heptares receives an upfront payment of $37 million on signing and is eligible to receive development and commercial milestones…

December 16, 2022 - 2 minutesmins - By Jim Cornall

Interview 27 Feb 2019

How to Make Cancer Drug Resistance Futile

…stop the cancer cells from developing resistance, letting the cancer drug work for longer. To identify promising add-on candidates, the company uses a robotic setup to screen thousands of drug…

February 27, 2019 - 5 minutesmins - By Jonathan Smith

News and Trends 5 Oct 2016

€365M deal for a Danish ‘DNA barcode’ Drug Screening Platform

…and GSK. In its latest partnership, the Danish Biotech will identify and advance potential drug candidates for Amgen, which will have exclusive rights to buy any successful program. The big…

October 5, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

blood cancer disease model, multi-omics, CAR-T, oncology

News and Trends 18 Dec 2019

Cellestia Secures €18M to Develop First-in-Class Cancer Drug

…end of last year. Cellestia’s drug candidate is currently being tested in a phase I trial in patients with blood cancers and solid tumors that have mutations in the Notch…

December 18, 2019 - 2 minutesmins - By Helen Albert

News and Trends 21 Dec 2022

Ethris and DIOSynVax to develop mRNA betacoronavirus vaccine

Ethris GmbH is to collaborate with U.K.-based DIOSynVax to jointly develop a protective mRNA vaccine candidate against a broad range of betacoronaviruses. The efforts will utilize Ethris’ mRNA modification and…

December 21, 2022 - 3 minutesmins - By Jim Cornall

Galecto Biotech BMS TD139 Phase Ia IIb 1

News and Trends 20 Mar 2017

Will BMS Take Over a Danish Biotech in a Massive €400M Deal?

Galecto Biotech has presented positive data from a Phase II study with its pulmonary fibrosis candidate, giving BMS the option of take over the biotech. In 2014, Denmark’s Galecto Biotech…

March 20, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 8 Jan 2020

Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment

…several others. Therachon’s lead candidate is a drug to boost bone growth in people born with the genetic condition achondroplasia. The company’s second candidate was a drug to help nutrient…

January 8, 2020 - 2 minutesmins - By Helen Albert

coronavirus COVID 19 Europe biotech lungs

News and Trends 22 Jul 2020

Inhaled Treatment Reduces Severe Covid-19 Risk by 79%

…In the trial, the lead candidate of UK-based biotech Synairgen drove down by 79% the risk of severe disease symptoms such as requiring mechanical ventilation in hospitalized Covid-19 patients. Among…

July 22, 2020 - 3 minutesmins - By Victor Kotsev

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Therapeutic Nanoparticle Companies Are Rare: Meet the CEO of One of Them

Seven molecular glue startups looking to stick around in the biotech industry

The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy

Sorry Scotland, Phase II Trial for Clinical Depression Fails against 55-Year Old Generic

Sosei Heptares and Lilly enter agreement on diabetes and metabolic diseases

How to Make Cancer Drug Resistance Futile

€365M deal for a Danish ‘DNA barcode’ Drug Screening Platform

Cellestia Secures €18M to Develop First-in-Class Cancer Drug

Ethris and DIOSynVax to develop mRNA betacoronavirus vaccine

Will BMS Take Over a Danish Biotech in a Massive €400M Deal?

Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment

Inhaled Treatment Reduces Severe Covid-19 Risk by 79%

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!